拉夏貝爾(603157.SH):實控人之一致行動人補充質押670萬股
格隆匯4月9日丨拉夏貝爾(603157.SH)公佈,公司於2020年4月9日接到通知,獲悉公司實控人的一致行動人上海合夏投資有限公司將所持有的公司670萬股有限售條件股份(均為A股股份)辦理了補充質押。
截止本公告披露日,上海合夏持有公司有限售條件股份4520.44萬股,佔公司總股本8.25%。本次補充質押後,上海合夏累計質押股份4520萬股,佔公司總股本8.25%,占上海合夏持有公司股份的99.99%。
本次補充質押後,公司控股股東及其一致行動人上海合夏累計質押公司股份1.87億股,佔公司總股本34.11%,佔控股股東及上海合夏合計持有公司股份的99.85%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.